Netherlands · Seed startup

Who invested in Avidicure

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

HealthcareEngineering

Funding summaryUpdated 26 Oct 2026

$50Mraised across 1 round since 2025, from 1 source

Latest round
Seed, $50MApr 2025
Investors
3
See who backed them

The rounds

  1. Apr 2025
    Seed$50M

    Source recorded

Founders and team

From Avidicure's own website: 7 on the team.

  • Arthur LahrCOO
  • Dirk De NaeyerCOO
  • Govert SchoutenHead of Discovery
  • Frank VerwielChairman
  • Helen CollinsChair SAB
  • Joern-Peter HalleChair SAB
  • Oliver NussbaumerBoard / SAB

Everyone who backed them

BOMVC firm1round
KurmaPartnersVC firm1round
EQT Life SciencesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Avidicure as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

V-Bio VenturesVC firmPer its own site
Curie CapitalVC firmPer its own site

Quick answers about Avidicure

Who invested in Avidicure?

Avidicure's investors include BOM, KurmaPartners and EQT Life Sciences.

How much has Avidicure raised?

Avidicure has raised $50M across 1 round since 2025.

When did Avidicure last raise?

Avidicure's most recent round was a Seed of $50M in Apr 2025.

What was Avidicure's biggest round?

Its most recent round, $50M in Apr 2025, is also its largest on record.

Who backed Avidicure first?

Avidicure's first round on record, in Apr 2025, was backed by BOM, KurmaPartners and EQT Life Sciences.

What stage is Avidicure at?

Avidicure's latest named round is a Seed, in Apr 2025.

Where is Avidicure based?

Avidicure is based in the Netherlands.

Companies like Avidicure

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.